切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2026, Vol. 20 ›› Issue (02) : 98 -105. doi: 10.3877/cma.j.issn.1674-1358.2026.02.005

论著

儿童社区获得性细菌性肺炎致病菌特点多中心研究
宋承旭1, 姚贵旭1, 田宇2, 王敏3, 周义东4, 刘亚芹5, 王妮1,()   
  1. 1 563000 遵义市,遵义市第一人民医院(遵义医科大学第三附属医院)儿科
    2 563000 遵义市,遵义市妇幼保健院儿科
    3 563000 遵义市,遵义市汇川区人民医院儿科
    4 563000 遵义市,遵义市红花岗区人民医院儿科
    5 563000 遵义市,遵义市播州区人民医院儿科
  • 收稿日期:2025-09-16 出版日期:2026-04-15
  • 通信作者: 王妮
  • 基金资助:
    遵义市科技计划项目(遵市科合HZ字(2023)65号)

Multicenter study on distribution of pathogens in pediatric community-acquired bacterial pneumonia

Chengxu Song1, Guixu Yao1, Yu Tian2, Min Wang3, Yidong Zhou4, Yaqin Liu5, Ni Wang1,()   

  1. 1 Department of Pediatrics, Zunyi First People’s Hospital (The Third Affiliated Hospital of Zunyi Medical University), Zunyi 563000, China
    2 Department of Pediatrics, Zunyi Maternal and Child Health Care Hospital, Zunyi 563000, China
    3 Department of Pediatrics, Zunyi Huichuan District People’s Hospital, Zunyi 563000, China
    4 Department of Pediatrics, Zunyi Honghuagang District People’s Hospital, Zunyi 563000, China
    5 Department of Pediatrics, Zunyi Bozhou District People’s Hospital, Zunyi 563000, China
  • Received:2025-09-16 Published:2026-04-15
  • Corresponding author: Ni Wang
引用本文:

宋承旭, 姚贵旭, 田宇, 王敏, 周义东, 刘亚芹, 王妮. 儿童社区获得性细菌性肺炎致病菌特点多中心研究[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(02): 98-105.

Chengxu Song, Guixu Yao, Yu Tian, Min Wang, Yidong Zhou, Yaqin Liu, Ni Wang. Multicenter study on distribution of pathogens in pediatric community-acquired bacterial pneumonia[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2026, 20(02): 98-105.

目的

探讨2020至2024年遵义地区儿童社区获得性肺炎(CAP)的病原菌分布特征及其随年份、年龄和季节的变化规律,为临床经验性抗感染治疗提供依据。

方法

回顾性收集遵义市5家医院住院治疗的细菌性病原体CAP患儿的临床资料,纳入痰培养阳性且符合CAP诊断标准的病例共21 546例,采用Pearson卡方检验分析不同发病年龄和季节病原菌构成特征,采用趋势卡方检验分析不同发病年份病原菌的分布。

结果

共入组21 546例痰培养阳性儿童CAP患儿,其中男性患儿13 307例(61.8%),女性患儿8 239例(38.2%);不同年份、季节、年龄分布差异均有统计学意义(χ2=1 103.4、1 083.9、3 733.9,P均<0.001)。革兰阴性菌和革兰阳性菌检出率年份分布差异具有统计学意义(χ2=189.5、P<0.001),2024年革兰阴性菌检出率反超革兰阳性菌(53.0% vs. 47.0%)。病原菌检出率前5位分别为流感嗜血杆菌(6 972例、32.4%)、肺炎链球菌(5 746例、26.7%)、金黄色葡萄球菌(3 825例、17.8%)、耐甲氧西林金黄色葡萄球菌(MRSA)(2 027例、9.4%)和大肠埃希菌(852例、4.0%)。年龄分布:婴儿组患儿以流感嗜血杆菌(3 344/11 073、30.2%)、金黄色葡萄球菌(2 702/11 073、24.4%)、大肠埃希菌(742/11 073、6.5%)感染为主;幼儿及学龄前患儿以肺炎链球菌[37.9%(2 228/5 879)和33.1%(1 217/3 672)]、流感嗜血杆菌[39.3%(2 308/5 879)和31.2%(1 145/3 672)]感染为主;学龄期患儿以MRSA检出率最高(348/922、37.7%)。季节分布:秋冬季细菌感染率较高,四季均以流感嗜血杆菌和肺炎链球菌为主,流感嗜血杆菌冬季检出率最高(2 627/6 238、42.1%),肺炎链球菌秋季占比最高(1 821/5 435、33.4%)。耐药性分析显示,流感嗜血杆菌对复方新诺明、氨苄西林、头孢呋辛高度耐药[耐药率分别为95.3%(6 644/6 972)、89.6%(6 247/6 972)和73.4%(5 142/6 972)],大肠埃希菌对氨苄西林、头孢呋辛和头孢曲松耐药率分别为91.1%(752/825)、83.0%(685/825)和78.4%(647/825),二者对哌拉西林/他唑巴坦、美罗培南均敏感;肺炎链球菌对四环素耐药率为100%(5 746/5 746),金黄色葡萄球菌对青霉素耐药率为92%(3 519/3 825),MRSA对克林霉素和红霉素耐药率均>90%,上述革兰阳性菌对万古霉素和利奈唑胺等均敏感。

结论

本地区CAP患儿病原菌检出率存在明显的年份、季节和年龄差异,2024年革兰阴性菌检出率反超革兰阳性菌,不同年龄段优势致病菌不同且秋冬季感染高发,常见致病菌对多种常规抗菌药物耐药严重,需要根据药敏试验结果选择合理抗菌药物。

Objective

To investigate the distribution characteristics of pathogens causing community-acquired pneumonia (CAP) in children in Zunyi region from 2020 to 2024, and to analyze their variations by year, age and season, in order to provide evidence for empirical anti-infection therapy.

Methods

Clinical data of hospitalized children with bacterial CAP from five hospitals in Zunyi were collected, retrospectively. Total of 21 546 cases with positive sputum cultures and meeting CAP diagnostic criteria were included. The pathogen spectrum and its distribution across different years, age groups and seasons were analyzed. The characteristics of pathogen composition across different ages and seasons were analyzed by Pearson Chi-square test, and the pathogen distribution across different years was analyzed by Chi-square trend test.

Results

Total of 21 546 children with CAP who had positive sputum cultures were enrolled, including 13 307 males (61.8%) and 8 239 females (38.2%). There were statistically significant differences in the distribution of children among different years, seasons and age groups (χ2=1 103.4, 1 083.9, 3 733.9; all P<0.001). The detection rates of Gram-negative bacteria and Gram-positive bacteria showed significant differences in distribution among different years (χ2=189.5, P<0.001), and the detection rate of Gram-negative bacteria (53.0%) exceeded that of Gram-positive bacteria (47.0%) in 2024. The top 5 pathogens in terms of detection rate were Haemophilus influenzae (6 972 cases, 32.4%), Streptococcus pneumoniae (5 746 cases, 26.7%), Staphylococcus aureus (3 825 cases, 17.8%), methicillin-resistant Staphylococcus aureus (MRSA) (2 027 cases, 9.4%) and Escherichia coli (852 cases, 4.0%). Age distribution: children in infant group were mainly infected with Haemophilus influenzae (3 344/11 073, 30.2%), Staphylococcus aureus (2 702/11 073, 24.4%) and Escherichia coli (742/11 073, 6.5%); children in the toddler and preschool group were mainly infected with Streptococcus pneumoniae [37.9% (2 228/5 879) and 33.1% (1 217/3 672)] and Haemophilus influenzae [39.3% (2 308/5 879) and 31.2% (1 145/3 672)]; children in the school-age group had the highest detection rate of MRSA (348/922, 37.7%). Seasonal distribution: the bacterial infection rate was higher in autumn and winter. Haemophilus influenzae and Streptococcus pneumoniae were the main pathogens in all four seasons, among which Haemophilus influenzae had the highest detection rate in winter (2 627/6 238, 42.1%) and Streptococcus pneumoniae had the highest proportion in autumn (1 821/5 435, 33.4%). Drug resistance analysis showed that Haemophilus influenzae was highly resistant to trimethoprim-sulfamethoxazole, ampicillin and cefuroxime [resistance rates were 95.3% (6 644/6 972), 89.6% (6 247/6 972) and 73.4% (5 142/6 972)]. The resistance rates of Escherichia coli to ampicillin, cefuroxime and ceftriaxone were 91.1% (752/825), 83.0% (685/825) and 78.4% (647/825), respectively, and Escherichia coli was sensitive to piperacillin/tazobactam and meropenem; The resistance rate of Streptococcus pneumoniae to tetracycline was 100% (5 746/5 746), while the resistance rate of Staphylococcus aureus to penicillin was 92% (3 519/3 825), and the resistance rate of MRSA to clindamycin and erythromycinhad were both higher than 90%, and all the above Gram-positive bacteria were sensitive to vancomycin, linezolid, etc.

Conclusions

There were significant differences in the detection rates of pathogens from children with CAP in Zunyi region among different years, seasons and age groups. In 2024, the detection rate of Gram-negative bacteria exceeded that of Gram-positive bacteria. The dominant pathogenic bacteria varied among different age groups, and the infection rates were higher in autumn and winter. Common pathogenic bacteria were highly resistant to various conventional antibiotics. It is necessary to select reasonable antibiotics according to the drug sensitivity test results.

表1 入组21 546例CAP患儿的基本资料
表2 不同发病年份CAP患儿革兰阴性菌和革兰阳性菌检出率 [例(%)]
表3 不同发病年份CAP患儿常见病原菌检出率 [例(%)]
表4 不同性别CAP患儿常见病原菌检出率 [例(%)]
表5 不同年龄组CAP患儿常见病原菌检出率 [株(%)]
表6 不同季节CAP患儿常见病原菌检出率 [株(%)]
表7 CAP患儿所检出革兰阴性菌对常见抗菌药物的耐药性 [株(%)]
表8 CAP患儿所检出革兰阳性菌对常见抗菌药物的耐药性 [株(%)]
[1]
Qiao J, Wang Y, Li X, et al. A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China[J]. Lancet,2021,397(10293): 2497-2536.
[2]
胡家康, 韩志英, 张俊艳. 儿童社区获得性肺炎病原学特点分析[J]. 中国实用儿科杂志,2023,38(5):381-385.
[3]
Meyer Sauteur PM. Childhood community-acquired pneumonia[J]. Eur J Pediatr,2024,183(3):1129-1136.
[4]
陆芸芸. 儿童重症社区获得性肺炎病原体分布及细菌耐药情况分析[D]. 重庆: 重庆医科大学,2018.
[5]
中华人民共和国国家卫生健康委员会, 国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志,2019,12(1):6-13.
[6]
尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社,2019,11:2335.
[7]
临床和实验室标准化协会. 抗微生物药物敏感性试验执行标准: CLSI增补文件M100[S]. 35版. 美国: 临床和实验室标准化协会,2025.
[8]
冯孝强, 宋建刚, 李元霞. 儿童社区获得性肺炎124例临床诊治回顾性分析[J]. 临床医学研究与实践,2022,7(17):19-22.
[9]
陈钟英, 曾妍, 高正炎. 儿童社区获得性肺炎病原学特征分析及预防对策[J]. 中国医药科学,2020,10(5):107-110.
[10]
O’Brien KL, Baggett HC, Brooks WA, et al. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case- control study[J]. Lancet,2019,394(10200):757-779.
[11]
李司鹏, 胡辉, 蓝陈福, 等. 丽水市632例儿童社区获得性肺炎流行病学调查与病原学特征分析[J]. 中国妇幼保健,2022,37(24):4698-4700.
[12]
李英, 汪奇伟, 商亚敏, 等. 儿童社区获得性肺炎病原菌及其疗效的影响因素[J]. 中华医院感染学杂志,2023,33(3):471-475.
[13]
Yang R, Xu H, Zhang Z, et al. The epidemiology of pathogens in community-acquired pneumonia among children in Southwest China before, during and after COVID-19 non-pharmaceutical interventions: a cross-sectional study[J]. Influenza Other Respir Viruses,2024,18(8):e13361.
[14]
韩鹏, 柳彬彬, 乔晶晶, 等. 儿童呼吸道病毒感染的非药物干预及其影响[J]. 中华实用儿科临床杂志,2022,37(6):466-470.
[15]
文荣虔, 齐书芳, 陈淑津. 佛山市南海区儿童重症社区获得性肺炎的呼吸道病原学分析[J]. 实用预防医学,2025,32(6):754-757.
[16]
赵波, 向超, 何苗, 等. 儿童社区获得性肺炎痰培养细菌分布及耐药性分析[J]. 医学临床研究,2024,41(6):857-860.
[17]
Benedictis FM, Kerem E, Chang AB, et al. Complicated pneumonia in children[J]. Lancet,2020,396(10253):786-798.
[18]
Lyon E, Olarte L. Community-acquired bacterial pneumonia in children: an update on antibiotic duration and immunization strategies[J]. Curr Opin Pediatr,2024,36(2):144-149.
[19]
李倩, 王伟伟, 崔方元, 等. 某市儿童社区获得性肺炎病原菌调查及耐药性分析[J]. 中国实用医药,2025,20(14):49-53.
[20]
蒋家敏, 霍开明, 韩栋光, 等. 海口地区儿童肺炎流行病学特点及病原菌耐药情况[J]. 中国临床研究,2022,35(8):1111-1114, 1119.
[21]
中华医学会儿科学分会呼吸学组, 中华儿科杂志编辑委员会, 中国医药教育协会儿科专业委员会. 儿童社区获得性肺炎管理指南(2024修订)[J]. 中华儿科杂志,2024,62(10):920-930.
[22]
Ensinck G, Lazarte G, Ernst A, et al. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia in a children’s hospital. Our ten-year experience[J]. Arch Argent Pediatr,2021,119(1):11-17.
[23]
尹冰如, 董晓艳. 不同病原感染所致的重症社区获得性肺炎的临床表现[J]. 中国实用儿科杂志,2022,37(2):104-110.
[24]
Sumitomo T, Kawabata S. Respiratory tract barrier dysfunction in viral-bacterial co-infection cases[J]. Jpn Dent Sci Rev,2024,60:44-52.
[25]
李婷, 陈婷. 2021-2023年某院鲍曼不动杆菌对常用抗菌药物的耐药检测结果[J]. 中国药物滥用防治杂志,2024,30(12):2208-2209, 2212.
[26]
Luo Y, Wu R, Wu W, et al. Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children[J]. BMC Pediatr,2025,25(1):449.
[27]
Zhao M, Shi Y, Zhang C, et al. Diagnostic value of metagenomic next-generation sequencing using bronchoalveolar lavage fluid samples for pathogen detection in children with severe or refractory pneumonia[J]. Microbiol Spectr,2025,13(3):e0108724.
[28]
Wei Y, Zhang T, Ma Y, et al. Clinical evaluation of metagenomic next-generation sequencing for the detection of pathogens in BALF in severe community acquired pneumonia[J]. Ital J Pediatr,2023,49(1):25.
[29]
孙芳, 王军, 孙钊宁, 等. 肺泡灌洗液宏基因二代测序在儿童重症肺炎中的应用[J/OL]. 中华实验和临床感染病杂志(电子版),2024,18(1):27-34.
[1] 陈晓晓, 林成寿, 吴锦清, 缪娟, 刘成招, 刘清平, 王旭, 陈武桂. 闽东地区5 320例髋部骨折住院患者临床特征分析[J/OL]. 中华关节外科杂志(电子版), 2026, 20(02): 174-184.
[2] 余珍燕, 王启明, 许超, 朱渝. 百日咳毒力基因变异与疫苗株抗原关联性研究进展[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 707-713.
[3] 王献珍, 王洪瑾, 李毅, 崔强. 青海省某三甲医院烧伤住院患者流行病学特征分析[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(04): 312-317.
[4] 张雨霖, 熊勇. JC多瘤病毒流行病学及诊疗研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(02): 93-97.
[5] 武晶, 张建军, 程琮玉, 尚翠, 史文雅, 任航, 司芬芬, 许京春, 李晨, 信振江, 李彦奇. 北京市丰台区丙型肝炎患者防治知识知晓和抗病毒治疗及其影响因素[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(01): 22-30.
[6] 周珣, 陈红兵. 2024年南京及周边地区呼吸道感染患儿病原体分布特点[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(01): 39-45.
[7] 李发英, 马杰, 于国英. 755例慢性丙型肝炎患者临床特征及进展为肝硬化的影响因素[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(05): 279-287.
[8] 张丽花, 胡耀华, 周春献, 张晓亭, 胡韶军. 恶性肿瘤患者住院化疗期间医院感染状况及列线图预测模型构建[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(04): 205-213.
[9] 李娅, 庄淑波. 124例慢性难愈创面患者病原菌分布特征和耐药性回顾研究[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(04): 230-241.
[10] 王加中, 曹罡, 刘阳, 陈硕, 李昊煜, 朱绵军, 郑博. 自身免疫性疾病与甲状旁腺功能亢进症的因果关联:孟德尔随机化研究[J/OL]. 中华普通外科学文献(电子版), 2026, 20(01): 35-40.
[11] 胡海贇, 惠舟奇, 王春, 张婷, 李晓露, 李丹, 张玲玲, 沈爱珠, 张静佳, 高欢欢. 39 025例上海儿童呼吸道病原体感染及流行病学特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 117-123.
[12] 谢伟, 张小峰, 沈锋. 肿瘤免疫治疗相关不良事件的流行病学特征、发生机制和防治策略[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 146-151.
[13] 秦虎, 李迪, 马木提江·木尔提扎, 李亚宾, 徐彬, 刘博, 夏平, 汪永新. 新疆维吾尔自治区创伤性脑损伤的流行病学特点[J/OL]. 中华神经创伤外科电子杂志, 2025, 11(05): 320-327.
[14] 周子靖, 谢剑锋, 薛明. 新型冠状病毒感染大流行期间侵袭性肺真菌病的变迁与挑战[J/OL]. 中华重症医学电子杂志, 2025, 11(03): 226-232.
[15] 高桃桃, 刘立福, 陈茵桐, 周颖璇, 邓小燕, 梁晓丽. 流行性感冒病毒继发细菌感染流行病学和致病机制研究进展[J/OL]. 中华临床实验室管理电子杂志, 2026, 14(01): 74-80.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?